Bausch + Lomb, a division of Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX), is solely dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our mission is simple yet powerful: Helping you see better to live better.
The company is one of the best-known and most respected healthcare brands in the world, offering the widest and finest range of eye health products including contact lenses and lens care products, pharmaceuticals, intraocular lenses and other eye surgery products.
Our highest priority is the well-being of the people we serve. By listening to our customers and patients, by constantly honing our innovation edge, by executing with integrity and excellence, we strive to earn the trust of our partners and stakeholders.
Over the last 150 years, Bausch + Lomb has become a global hallmark for innovation and quality. Our talented and motivated colleagues work relentlessly to invent new materials, engineer new technologies, and ultimately bring new innovations to help people see better to live better.
We Market Three Broad Categories Of Products
Vision Care: Our contact lens offerings span the entire spectrum of wearing modalities and include such well-known brand names as PureVision2, Biotrue ONEday and Boston. Our lens care products include Biotrue, PeroxiClear and renu brand of chemical disinfectants for soft contact lenses as well as the Boston line of products for cleaning gas permeable contact lenses.
Pharmaceuticals: Our products treat a wide range of eye conditions including glaucoma, eye allergies, conjunctivitis, dry eye and retinal diseases. We offer proprietary and generic medicines available by prescription, over-the-counter eye drops and other medications. Our line of proprietary Rx products includes the antibacterial eye drops Besivance, the steroid eye drops Lotemax, Alrex, Liposic ointment for dry eye, and Retisert used fortreating retinal diseases. Outside the U.S., we offer the nonselective beta blocker, Carteol. Leading OTC products include the Ocuvite and PreserVision brands of ocular vitamins.
Cataract and Vitreoretinal Surgery: We offer a full suite of products including intraocular lenses and delivery systems featuring the Crystalens, SofPort and Akreos brands of IOLs, the Stellaris and Millennium lines of phacoemulsification equipment, and other surgical instruments and devices, including the Storz line of instruments.
At a Glance
The company began in 1853 in Rochester, New York, as a small optical shop that grew to become a multi-billion dollar corporation with approximately 10,000 employees worldwide, and with products available in more than 100 countries. In October 2007, Warburg Pincus led the acquisition of Bausch + Lomb, which had previously been a publicly traded NYSE company. In August of 2013, Bausch + Lomb was acquired by Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and became the eye care division of Valeant.